Enhancing Tissue Engineering/Regenerative Medical Product Commercialization: The Role of Science in Regulatory Decision Making for Tissue Engineering/Regenerative Medicine Product Development-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Enhancing Tissue Engineering/Regenerative Medical Product Commercialization: The Role of Science in Regulatory Decision Making for Tissue Engineering/Regenerative Medicine Product Development

Published:2013-11 Issue:21-22 Volume:19 Page:2313-2313
ISSN:1937-3341
Container-title:Tissue Engineering Part A
language:en
Short-container-title:Tissue Engineering Part A

Author:

Bertram Timothy A.¹,Johnson Peter C.²,Tawil Bill³,Van Dyke Mark⁴,Hellman Kiki B.⁵

Affiliation:

1. Tengion, Inc., Winston-Salem, North Carolina.

2. Scintellix, LLC, Raleigh, North Carolina.

3. Department of BioSurgery, Baxter BioScience, Westlake Village, California.

4. Department of Biomedical Engineering, Virginia Polytechnic Institute and State University, Blacksburg, Virginia.

5. President and CEO, The Hellman Group, LLC, Clarksburg, Maryland.

Publisher

Mary Ann Liebert Inc

Subject

Biomedical Engineering,Biomaterials,Biochemistry,Bioengineering

Link

https://www.liebertpub.com/doi/pdf/10.1089/ten.tea.2013.0536

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How Regenerative Medicine Stakeholders Adapt to Ever-Changing Technology and Regulatory Challenges? Snapshots from the World TERMIS Industry Symposium (September 10, 2015, Boston);Tissue Engineering Part B: Reviews;2017-04

2. The Maturation of Tissue Engineering;Tissue Engineering Part A;2015-10

3. Corrections;Tissue Engineering Part A;2013-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP